Skip to main content
. Author manuscript; available in PMC: 2014 Aug 4.
Published in final edited form as: Mod Pathol. 2009 Aug 28;22(11):1446–1456. doi: 10.1038/modpathol.2009.116

Table 4.

Acral lentiginous/ mucosal melanoma cases positive for KIT mutation

Case Diagnosis Kit mutation KIT IHC (%) KIT IHC (intensity)
28 AL, primary, left foot Exon 11, L576P 5–50 1+
46 AL, primary, left foot Exon 17, D816V 51–95 3+
82 AL, primary, left foot Exon 11, 566 to 572 del 5–50 1+
52 AL, met, inguinal LN (left foot primary) Exon 13, N655K >95 3+
60 AL, met, skin (left toe primary) 1 Exon 11, V559Aa 51–95 2+
6 Muc, primary, anus/rectuma Exon 11, V560Da 51–95 3+
10 Muc, primary, vulva Exon 11, L576P 51–95 3+
20 Muc, primary, vaginaa Exon 17, D816Va 51–95 2+
38 Muc, primary, conjunctiva Exon 11, V559G >95 2+
88 Muc, primary, palate Exon 11, 566 to 574 del 51–95 2+
120 Muc, primary, anus/rectum Exon 11, L576P >95 3+
127 Muc, primary, vulva Exon 13 (K642E) and 17 (N822I) >95 2+
159 Muc, primary, vulva Exon 13, K642E >95 3+
162 Muc, primary, anus/rectum Exon 11, L576P >95 3+

AL: acral lentiginous; Muc: mucosal; met: metastasis.

a

Mutation analysis performed on both primary and metastatic tumors showed the same genetic defect.